FdaApplication

NDA 020235

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIATRIS SPECIALTY LLC
application_typeNDA
approval_date1993-12-30

Products (3)

ProductActive ingredientStrengthDosage form
NEURONTINGABAPENTIN300MGCAPSULE;ORAL
NEURONTINGABAPENTIN400MGCAPSULE;ORAL
NEURONTINGABAPENTIN100MGCAPSULE;ORAL

3 products